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Abstract
Background: With the advent of inexpensive assay technologies, there has been an
unprecedented growth in genomics data as well as the number of databases in
which it is stored. In these databases, sample annotation using ontologies and
controlled vocabularies is becoming more common. However, the annotation is
rarely available as Linked Data, in a machine-readable format, or for standardized
queries using SPARQL. This makes large-scale reuse, or integration with other
knowledge bases very difficult.
Methods: To address this challenge, we have developed the second generation of our
eXframe platform, a reusable framework for creating online repositories of genomics
experiments. This second generation model now publishes Semantic Web data. To
accomplish this, we created an experiment model that covers provenance, citations,
external links, assays, biomaterials used in the experiment, and the data collected during
the process. The elements of our model are mapped to classes and properties from
various established biomedical ontologies. Resource Description Framework (RDF) data
is automatically produced using these mappings and indexed in an RDF store with a
built-in Sparql Protocol and RDF Query Language (SPARQL) endpoint.
Conclusions: Using the open-source eXframe software, institutions and laboratories
can create Semantic Web repositories of their experiments, integrate it with
heterogeneous resources and make it interoperable with the vast Semantic Web of
biomedical knowledge.
Background
There has been a rapid cost reduction per megabase of genomic information obtained,
beating Moore’s law [1] many-fold [2,3], resulting in an exponential growth of geno-
mics data, especially next generation sequencing data [4]. Standards to unambiguously
describe the experimental details are required to facilitate the understanding, quality
checking, reusing, reproducing and integrating the data. The bioinformatics community
has responded to the challenge and several standards have been developed over the
years. The first standard to be published provided requirements for the Minimum
Information About a Microarray Experiment (MIAME) [5]. Several other standards
were published as new technologies evolved and then the Minimum Information for
Biological and Biomedical Investigations guideline was proposed for reporting all types
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Gene Expression Omnibus (GEO) [7] and ArrayExpress [8], are compliant with these
standards.
While standards addressed the need for uniform experiment representation, controlled
vocabularies, terminologies and ontologies were developed to describe the samples, assays
and other experimental details in an unambiguous manner. For example, the Ontology for
Biomedical Investigations (OBI) [9] provides a model for biomedical experiments with
classes that describe elements of the experimental investigation process. The Experimental
Factor Ontology (EFO) [10] was developed as an application ontology to describe the
genomics data in ArrayExpress [8]. In addition several ontologies and vocabularies have
also been developed to describe biological specimens such as the organism, tissue, cell
type, disease state. These include the Cell Ontology (CL) [11], the Foundation Model of
Anatomy (FMA) [12], Disease Ontology (DO) [13] among numerous others.
Several repositories of genomics data have adopted the MIAME or MIBBI standards and
are leveraging these biomedical ontologies to provide consistent annotation of experi-
ments. A few examples from diverse domains include the Gemma repository - a resource
for sharing, reuse and meta-analysis of microarray data [14], Chemical Effects in Biological
Systems (CEBS) database that contains data of interest to environmental health scientists
[15] and Oncomine an integrated database and mining platform for oncology data mine
[16]. Although these resources make use of ontologies to represent experimental data in a
standardized manner, the annotations are not machine-readable by other software and
thus integration with other knowledge resources remain a challenge.
Meanwhile, Semantic Web [17] technologies such as Linked Data, Resource Description
Framework (RDF) and SPARQL are increasingly being used in the bioinformatics commu-
nity to respond to the knowledge integration needs [18]. Semantic Web allows one to
query across disparate resources using a single flexible interface. For example, the Bio2RDF
project successfully applies Semantic Web technologies to create a mashup of key publicly
available databases using a common ontology and normalized Uniform Resource Identifiers
(URI) [19,20]. Cheung et al. demonstrate the use of Semantic Web technologies for a
federated query in the neuroscience domain [21]. There are several other examples across
various biomedical domains that demonstrate the power of Semantic Web technologies.
However, surprisingly there has been no wide spread adoption of Semantic Web
technologies for experiment repositories, where queries using domain ontologies can
help bridge different disciplines, for important applications such as translational
medicine. Recently the European Bioinformatics Institute (EBI), recognizing this urgent
need, has released an RDF platform that includes a SPARQL endpoint for the Gene
Expression Atlas [22], a database that summarizes gene expression from ArrayExpress
experiments[23]. However, it doesn’t provide reusable software that can be used by
other institutions to house and query their genomics data.
To address this gap, we developed eXframe as a reusable software platform to build
genomics repositories that automatically produce Linked Data and a SPARQL
endpoint. Our platform is based on an open source content management system and
uses existing biomedical ontologies to produce Semantic Web data enabling intero-
perability with the other resources. The code is freely available and application is
demonstrated with a repository of stem cell data.
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In this section we describe the implementation of eXframe and how it automatically
generates Linked Data.
Framework
The eXframe software framework [24] enables creation of web-based genomics experi-
ment repositories. It is based on an open source content management system, Drupal
[25], with modifications to support genomic experiment data. In this paper, we report a
re-factored second generation of eXframe, which produces Linked Data and a SPARQL
endpoint for querying it. The revised version also includes an updated experiment
model that has been generalized to support various types of biomedical experiments as
well as an upgrade to Drupal 7.
We have defined content types (e.g. experiments, assays, biomaterials and bibliographic
citations) as well as their relationships as first class objects in Drupal. These predefined
content types are packaged as Drupal features and available for use within eXframe. All
content types and their fields are mapped to appropriate ontologies and vocabularies as
described in the following section. Using these mappings, the Drupal RDF modules [26]
are used to produce RDF as well as a SPARQL endpoint. Data can also be exported in
other standard formats such as ISA-Tab [27]. A simple schematic of the architecture is
shown in Figure 1. The software also includes a basic theme (colors, fonts and style) for
the website. Any group or institution that uses eXframe can customize the content types,
theme or ontology mappings.
Data model
The main content type within eXframe is an experiment. It describes the experiment
and its meta-data including title, description, contributors, design, citations, and links
Figure 1 eXframe architecture. Overall schematic of eXframe architecture displaying the major
components.
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is mapped to the OBI investigation class obo:investigation. The experiment’s “publication”
meta-data is represented using the Dublin Core ontology [29]. However, we are currently
evaluating the PAV ontology [30] as it provides more detailed and precise provenance
information. For example, the Dublin Core ontology specifies the relation dc:date;b u td o e s
not provide precise information as to whether the date is the “submitted date”, “published
date” or “last updated date”. The researchers that conducted the experiment are repre-
sented as Drupal users with a profile and mapped to foaf:Person in the FOAF ontology
[31]. While we do not specify the principal investigator (for the sake of simplicity), one
could use VIVO [32] to do so. Bibliographic citations are represented using the Drupal
biblio module and mapped to the bibliographic ontology, BIBO [33]. These classes and
mappings are illustrated in Figure 2.
The experiment class also describes the overall protocol; measurement type and
includes the experimental-factors, which can be exploited by bioinformaticians for data
analysis. Experiments are composed of assays represented by the bioassay content type.
Figure 2 Data Model. Data model outlining the relationship between the experiment, its assays and
biomaterials. The Drupal content types are indicated as green circles with the mapping listed underneath.
Arrows indicate the relationships.
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form used and other assay details. Bioassays are typically performed on several repli-
cates specified by the replicate content type and mapped to efo:replicate (OBI only
models replicate design and analysis). Each replicate is associated with the biological
material on which the assay is conducted and is specified by the biomaterial content
type. Thus technical replicates reference the same biomaterial, whereas biological repli-
cates reference the unique materials used for the assay. The assays have raw data as
their output. Data transformations and analyses conducted on the raw data are cur-
rently not represented, but are included in future plans for the system.
Biomaterial is deeply annotated using Drupal Taxonomies and mapped to various
controlled vocabularies and ontologies. In the eXframe default package, the organism,
tissue type, cell type, disease state and chemical treatment taxonomies are mapped to
NCBI Taxonomy (NCBITaxon) [34], FMA [12], CL [11], Disease Ontology (DO) [13]
and Chemical Entities of Biological Interest Ontology (ChEBI) [35] terms, respectively.
EFO [10], NCI Thesaurus [36] or Breda Tissue Ontology (BTO) [37] is also used to
increase coverage when required. Biomaterial properties and their mappings are config-
urable and can be easily customized to a particular domain as required. The mappings
of the main content types (experiments, bioassay, citation, biomaterials etc.) to ontolo-
g i e sa r ec o n f i g u r e di nP H Pc o d e ,i nas i n g l ef i l e( a ne x c e r p to fw h i c hi ss h o w ni n
Figure 3). Attributes of the experiment, bioassays, and biomaterials that can be defined
via structured vocabularies are stored as Drupal taxonomies. For example, “Cell Type”,
an attribute of the biomaterial, is represented as taxonomy. Each term in the taxonomy
is mapped to a class or classes in external ontologies. Thus, “Fibroblast” at e r mi nt h e
“Cell Type” taxonomy, is easily added, edited and mapped to ontologies through the
web interface.
Linked data & SPARQL endpoint
We use the Drupal RDF modules to produce RDF using the mappings discussed above.
RDF generated using the Drupal modules [26] is indexed into an RDF store powered
by the ARC2 PHP library [38]. A SPARQL endpoint is also published by this RDF
store. The RDF indexer in Drupal is designed to be backend-agnostic and allow for
any RDF store to be plugged in. We’re using ARC2, which is sufficient for our needs,
but other stores can be used depending on the size of the dataset, or particular
SPARQL features that might be needed.
Some of the data in the repository is kept private until the researchers publish their
work. To maintain privacy, we utilize two stores: one of which solely contains the
Figure 3 Ontology mapping code. Excerpt from exframe.entity_rdf.inc showing how Drupal classes are
mapped to external ontologies.
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tains the entire data and is kept secure using an API key. The secure, administrative
endpoint is used by R scripts (described in the next section) to access data for query
and analysis by members who have access authorization. The other benefit of having
decoupled stores is that we have the flexibility of optimizing the performance and scal-
ability of each store independently from the other.
R Integration
We wanted to provide programmatic access to the repository data to retrieve experi-
mental information in a manner that is independent of the Drupal database schema.
The R statistical programming language [39] and platform is a popular tool for analyz-
ing genomics data. Thus, we decided to provide support for accessing RDF data and
the SPARQL endpoint using R. The publicly available R packages to access RDF data
are not yet fully featured; for example the SPARQL package doesn’t support
DESCRIBE queries. Hence the RDF package that does support DESCRIBE statements
was used to provide information about the resources. Using the package, first the
experiment RDF is used to obtain information about the assays, and then the assays
provide information about the biomaterial (See relationships in Figure 2). The RDF
package also had problems; it is hindered by UTF8 encoding issues. The resulting R
scripts included in the eXframe package produce data structures compatible for analy-
sis with R packages such as BioConductor [40,41].
Results
Case study: Stem Cell Commons
Stem Cell Commons (SCC) is a project of the Harvard Stem Cell Institute (HSCI) to
freely share biomedical data, tools and resources within the research community [42].
Our platform, eXframe, was first implemented independently for the Blood genomics
program at HSCI, and then later extended to support all researchers at the Institute, as
the repository of Stem Cell Commons. Data from both the previously developed Blood
Genomics store and the Stem Cell Discovery Engine (SCDE) [43] was merged into the
eXframe-based SCC database.
Genomics datasets are actively curated into the database; currently the repository con-
tains over 200 datasets from 20 laboratories representing 4 organisms and 119 different cell
types and 39 tissue types. Results based on approximately half of the datasets (86) have
been published in scientific journals, and these datasets are therefore available to the public.
All bioassays and samples have been deeply annotated with ontologies. First we used
the OBI ontology [9] for the main entities (experiment, biomaterial and assays) as
described in the data model section. Dublin Core [29] and FOAF [31] were used for the
metadata and researcher respectively. The ontologies used to annotate the biomaterials
are listed in Table 1. All the Stem Cell Commons public data is available as Linked Data
as well as a SPARQL endpoint as described in the next sections.
RDF generation
RDF for the experiment, bioassay and biomaterials are automatically generated using
the Drupal RDF modules as described previously. A screenshot of actual RDF output
for an experiment curated in the Stem Cell Commons is depicted in Figure 4. It is a
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DNA methylation (using bisulphite sequencing) in the leukemia cell line K562, repro-
grammed leukemia cell lines (LiPS) and the human embryonic stem cell line H1. From
Figure 4, we see how the Dublin Core ontology provides the provenance information
for the experiment. The bibliographic citations and external references are stated. The
assay resources that are part of the experiment are listed using the has_part relation.
The experiment has 6 assays performed on the cell lines with various passages. The
protocol details are mostly described using a combination of OBI terms when available
Table 1 Ontologies used in Stem Cell Commons.
Content Type Attribute Ontology
Biomaterial Organism NCBITaxon [34]
Biomaterial Development Stage EFO [10]
Biomaterial Tissue Type FMA [12], EFO [10], BTO [37]
Biomaterial Cell Type CL [11], EFO [10]
Biomaterial Disease State NCI Thesaurus [36]
Biomaterial Treatment CHEBI [35], NCI Thesaurus [36]
Following ontologies were used to annotate the samples (biomaterial content type).
Figure 4 Screenshot of experiment RDF.L i n k e dd a t af r o mS t e mC e l lC o mmons illustrates use of DC,
FOAF and OBI ontologies to describe an experiment, which is a DNA methylation experiment performed
on various cell-lines with different passages. Available at: http://stemcellcommons.org/node/13610.rdf.
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tool to run, is described using the deprecated MGED ontology [44,45], as this term
doesn’t exist in any other ontology. The measurement type value - “DNA Methylation
Profiling (Bisulphite Sequencing)” - is however described in OBI. The experimental
factor (cell-line in this case) is also stated.
The DNA Methylation differences were measured in the various cell lines. The link to
each of the biomaterials and corresponding RDF is available from the main experiment
page (http://stemcellcommons.org/node/13610). Again, the biomaterial properties -
organism, tissue, cell-lines and disease state properties were fully annotated using ontol-
ogies (details listed in Table 2). All terms were mapped to the normalized OBO Foundry
ontologies [46] except “H1” where the EFO ontology was used. Such deep annotation
with ontologies not only provides disambiguation; but also more importantly allows us
to fully utilize the relations and properties that are defined in the external ontologies, as
described in the next section. While annotation with ontologies providing term ratifica-
tion is available in several repositories, SPARQL query capabilities like ours are not
commonly available.
SPARQL query
We list a query to find experiments done on mouse, hematopoietic stem cells in Table 3
that can be run on the SCC public SPARQL endpoint [47]. The public endpoint returns
the 14 publicly available datasets whereas the admin endpoint can access all 25 records.
We can load and integrate with external ontologies, such as the CL ontology, into the triple
s t o r eu s i n ge a s y - t o - u s eD r u p a lA P I st ot h eA R C 2l i b r a r y[ 3 8 ]( s e eF i g u r e5 ) .T h e nw el e v e r -
age the properties and relationships defined in CL to find all the experiments performed on
myeloid cells (CL_0000763) defined as “A cell of the monocyte, granulocyte, mast cell,
megakaryocyte, or erythroid lineage.” The query returns all available experiments per-
formed on myeloid cells - granulocyte monocyte progenitor cell, megakaryocyte-erythroid
progenitor cell, mast cell progenitor, myeloblast, monoblast, metamyelocyte, myelocyte and
promyelocyte (Figure 6). Similar queries to find experiments on cells involved in a pathway
or using synonyms defined in CL can also be performed.
Discussion
We have developed a reusable framework for creating genomics experiment knowledge
bases with powerful human and machine interfaces including user-friendly GUI, R inter-
face and SPARQL query against semantic experiment descriptors in RDF. Using the plat-
form, researchers in academic or private institutions can manage their experiments and
Table 2 Biomaterial property mappings.
Attributes Value Mapping
organism Human obo:NCBITaxon_9606
tissue Blood obo:UBERON_0000178
cell-line K562 obo:CLO_0007060
cell-line H1 (hESC) efo:EFO_0003042
disease state Myeloid Leukemia obo:DOID_8692
obo:http://purl.obolibrary.org/obo/
efo:http://www.ebi.ac.uk/efo/
All biomaterial properties are mapped to OBO Foundry ontologies, or the EFO ontology.
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The structured repository serves as an institutional memory of research done in a labora-
tory and facilitates data publication. Not only does the eXframe platform make data shar-
ing easy, it also allows researchers and the bioinformatics community to query this data
via SPARQL in a flexible manner, while respecting data privacy. This was a major
enhancement from the previous version. The new platform was deployed for the Stem
Cell Commons project. In the results section, we demonstrate how to query the SCC data
and the CL ontology in a single query, thus successfully exploiting the relationships stated
in the CL ontology and integrating it with the repository information.
An important aspect of the work was to map the different elements of an experiment
to and annotate bioassays and samples with existing biomedical ontologies. Our goal
was to reuse rather than create yet another new ontology; but the approach had its
challenges. To the extent possible, we use orthogonal ontologies as defined by the
Open Biomedical Ontologies (OBO) foundry [46]. There was no single ontology that
d e f i n e da l lt h er e q u i r e dc l a s s e sa n dr e l a t i onships; we had to use a heterogeneous mix
of ontologies and each had to be individually maintained within our system. Often
terms are missing or are not an exact match and a few times we had to use the depre-
cated MGED ontology (example presented in RDF generation section in Results).
Another issue faced was the stability of resource identifiers. For example, the new ver-
sion of the CL ontology includes identifiers (URIs) whose path is different from the
old ones. While the old URIs resolve to the new ones, our databases and SPARQL
endpoint had to be manually updated. Overcoming these challenges was a necessary
step, as standardized representation of experiments is required for interoperability.
By creating a framework for new repositories that applies existing biomedical ontolo-
gies and publishes Semantic Web data, we not only lower the barrier to producing
Table 3 Sample SPARQL query.
PREFIX obo: <http://purl.obolibrary.org/obo/>
PREFIX ro: <http://purl.org/obo/owl/ro#>
PREFIX dc: <http://purl.org/dc/terms/>
PREFIX ao: <http://purl.org/ontology/ao/core#>
PREFIX foaf: <http://xmlns.com/foaf/0.1>
SELECT DISTINCT ?title WHERE {
?experiment a obo:OBI_0000066 ;
dc:title ?title ;
ro:has_part ?bioassay .
?bioassay obo:OBI_0000293 ?replicate .
?replicate ro:is_a ?biomaterial .
?biomaterial obo:CL_0000000 ?cell_type .
?cell_type ao:preferred_equivalent obo:CL_0000037.
?biomaterial obo:OBI_0100026 ?organism .
?organism ao:preferred_equivalent obo:NCBITaxon_10090.
}
Sample SPARQL query to retrieve experiments performed on mouse hematopoietic cells.
Figure 5 Code snippet to load external ontologies. The two lines of code are required to connect and
load the CL ontology.
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vide a powerful mechanism to query data across knowledge bases from different
domains. Although federated SPARQL queries are not supported by the RDF store we
used, it is a first step towards interoperable genomics data. Given that eXframe was
designed to allow any RDF store in the backend, federation could be achieved by
choosing a different store with federation capabilities. As multiple research centers
adopt eXframe, one can envision running queries across centers and with other biome-
dical knowledge bases; thus fully exploiting the power of the Semantic Web.
Querying and integration across databases is crucial to translational medicine where
the need to bridge clinical and biological information is significant. To further enhance
the integration capabilities, our next step will be to include the results of the computa-
tional analysis in the SPARQL endpoint. For example, this will allow us to query for
gene expression changes in a pathway, spot histone modifications that result in expres-
sion changes, and identify transcripts whose expression is affected by transcription
factor binding.
There are several databases that use ontologies to annotate the data; such as the ones
listed in the Background section - Gemma repository [14], Chemical Effects in Biological
Systems (CEBS) database [15] and Oncomine [16] ). The annotation is successfully utilized
to make within-database queries. However flexible queries across knowledge resources
cannot be done without the use of Semantic Web technologies such as those we provide.
Figure 6 SPARQL query run on Stem Cell Commons public endpoint. Screenshot of SPARQL query
run on the public Stem Cell Commons endpoint that integrates repository data with the CL ontology.
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Array Express data; our reusable platform enables institutions to create their own endpoint,
and then query and integrate it with the vast web of existing knowledge bases.
Availability and requirements
eXframe is freely available at:
https://github.com/mindinformatics/exframe under the GPL version 2 free software
license. The eXframe framework runs on a LAMP stack, and uses the PHP and R
programming languages. The web application is supported on all modern browsers.
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